Kinetic and thermodynamic studies have been made on the effect of the inosine product on the activity of adenosine deaminase in a 50 mM sodium phosphate buffer, pH 7.5, at 27 o C using UV spectrophotometry and isothermal titration calorimetry (ITC). A competitive inhibition was observed for inosine as a product of the enzymatic reaction. A graphical-fitting method was used for determination of the binding constant and enthalpy of inhibitor binding by using isothermal titration microcalorimetry data. The dissociation-binding constant is equal to 140 µM by the microcalorimetry method, which agrees well with the value of 143 µM for the inhibition constant that was obtained from the spectroscopy method.
Introduction
Adenosine deaminase (ADA, EC 3.5.4.4), a key enzyme in purine metabolism, catalyzes the irreversible hydrolytic deamination of active adenosine (or 2'-deoxy-adenosine), which yields the inactive metabolite inosine (or 2'-deoxyinosine) and ammonia. It is present in virtually all mammalian cells, and is known to occur in several isoenzymatic and molecular forms (Hirchhorn and Ratech, 1980) . A deficiency of ADA activity is associated with a form of severe combined immunodeficiency disease (SCID) (Giblet et al., 1972; Valentine et al., 1977) . Also, a 40-to 70-fold increase of its activity is associated with a form of chronic nonspherocytic hemolytic disease (Daddona et al., 1978) .
Enzyme abnormalities have also been reported in some leukemia diseases (Murray et al., 1985) and in acquired immunodeficiency syndrome (AIDS) (Murray et al., 1985; Wilson et al., 1991) . It has been suggested that modulating ADA activity may be a target for chemotherapy. Therefore, ADA inhibitors may be used both as drugs and co-drugs in combination with certain anticancer or antiviral agents which are adenosine analogues (Glazer, 1980a, b; Lee et al., 1984) .
ADA is a glycoprotein that consists of a single polypeptide chain of 311 amino acids. It was sequenced in 1984 (Doddona et al., 1984) . The primary amino acids sequence of ADA is highly conserved across species (Chang et al., 1991) . Studies on the crystal structure of mouse ADA show that the protein is composed of an eight-stranded α/β motif with five additional α-helices, and the active site is located in the β-barrel -COOH terminal end (Wilson et al., 1991) . The crystal structure also revealed that ADA is a metalloenzyme that complexes one mole of Zn 2+ per mole of protein. The zinc ion is located deep within the substrate-binding cleft, and coordinated in a tetrahedral geometry to three Nε 2 atoms of His-15, His-17, and His-214, as well as the Oδ 2 of Asp-295. A water molecule, which shares the ligand coordination site with Asp-295, is polarized by the metal that gives rise to a hydroxylate ion that replaces the ammonia at the C-6 position of adenosine through a stereospecific addition-elimination mechanism. Experiments confirm that in the active enzyme, zinc plays a critical role in catalysis (Bhaumik et al., 1993) . It was reported that a secondary metal binding site(s) is available that would allow some metal ions to inhibit the holoenzyme (Cooper et al., 1997) .
The function of ADA is critical in controlling the effect of adenosine in other systems. Adenosine is an endogenous antihypoxic and anticonvulsant, as well as a modulate of platelet aggregation, lipolysis, glycogenolysis, blood flow, and neurotransmission (McIlwain, 1983; Stone, 1989) . Therefore, *To whom correspondence should be addressed. Tel: 0098-21-6498819; Fax: 0098-21-6404680 E-mail: saboury@chamran.ut.ac.ir the modulation of ADA with the use of highly specific inhibitors might modify the action of endogenous adenosine under various physiological and pathological conditions (Agarwal, 1982; Phillis et al., 1985; Centelles et al., 1988) . In this study, we investigated the inhibitory effect of the inosine product on the enzymatic reaction of ADA by spectroscopy and calorimetric methods.
Material and Methods
Materials Adenosine deaminase (type IV) from calf intestinal mucosa, adenosine, and inosine were obtained from Sigma. All of the other chemicals were of highest grade available from chemical sources. The solutions were prepared in doubly distilled water.
Enzyme assay The enzyme activity was assayed by uv-vis spectrophotometry using a Shimadzu-3100 instrument. This was followed by a decrease in the absorbance at 265 nm that is due to the conversion of adenosine to inosine, based on the Kaplan method (Kaplan, 1955) , that used the change extinction coefficient of −8400 M -1 cm -1 for adenosine. The standard assay mixture contained a final volume of 1 ml. The concentration of enzyme in the assay mixture was 0.94 nM. Assays were carried out in a 50 mM sodium phosphate buffer, pH = 7.5. The activities were measured over at least seven different concentrations of adenosine. The assays were repeated at least three times. The adenosine concentration range is between 0.25 to 2.5 K m . Care was taken to use adequate experimental conditions in order to keep the enzyme reaction linearity during the first minute of the reaction.
Calorimetric measurement
The isothermal titration microcalorimetric experiments were performed with the 4-channel commercial microcalorimetric system, Thermal Activity Monitor 2277, Thermometric, Sweden. Each channel is a twin heatconduction calorimeter where the heat-flow sensor is a semiconducting thermopile (multi-junction thermocouple plates) that is positioned between the vessel holders and surrounding heat sink. The insertion vessel was made from stainless steel. The inosine solution (2 mM) was injected by a Hamilton syringe into the calorimetric stirred titration vessel, which contained 1.8 ml enzyme, 0.75 mg/ml, including a phosphate buffer (50 mM), pH = 7.5. Thin (0.15 mm inner diameter) stainless steel hypodermic needles (permanently fixed to the syringe) reached directly into the calorimetric vessel. The injection of the inosine solution into the perfusion vessel was repeated 20 times. Each injection included 15 µl reagent. The calorimetric signal was measured by a digital voltmeter that was part of a computerized recording system. The heat of each injection was calculated by the "Thermometric Digitam 3" software program. The heat of the dilution of the inosine solution was measured as described previously, except the enzyme was excluded. The enthalpy of the dilution was subtracted from the enthalpy of the enzyme-inosine interaction. The enthalpy of the dilution of the enzyme was negligible. The microcalorimeter was frequently calibrated electrically during the course of the study.
In all of the calculations, the molecular weight of ADA was taken to be 34500 (Brady and OSullivan, 1967) . Figure 1 shows the activity of ADA against the adenosine substrate concentration. The decreased activity of ADA above the 0.11 mM concentration of substrate is related to the inhibition of the enzyme by the substrate (Blum and Schwedt, 1998) and product inosine. The double reciprocal LineweaverBurk plots for ADA in different fixed concentrations of inosine (pH = 7.5 and T = 300 K) are shown in Fig. 2a . The value of V max is unchanged by the inosine, but the apparent Michaelis constant (K m ') value is increased. This confirms the competitive inhibition of inosine on ADA. The values of K m ' at any fixed concentration of inosine were obtained from Fig. 2a and plotted versus concentrations of inosine in Fig. 2b (named a secondary plot) in order to obtain the inhibition constant (K I ). The results are as follows:
Results and Discussion
The Michaelis-Menten constant (K m ) that was obtained from these experiments is identical to that of a previous report (Moosavi-Movahedi et. al, 1993) .
By titration of a solution that contained an enzyme (E) with a solution of inhibitor (I), the equilibrium reaction moves toward increasing the concentration of the EI complex. The heat value of the reaction depends on the concentration of the EI complex. Therefore, the reaction under consideration can be written as follows:
and also
Equation (2) can be solved for [I] and this then substituted into the equation (3), which can then be rearranged to give the quadratic equation its only real root as: 
The sum of the heat evolutions that follows the i:th titration step, q i , can be expressed as
Where V i is the volume of the reaction solution and DH is the enthalpy of binding. The combination of equations (4) and (6) will lead to
where
A i , B i , and C i can be calculated in each injection, so equation (7) contains two unknowns, K and ∆H. A series of reasonable value for K is inserted into equation (7), and corresponding values for ∆H are calculated and the graph ∆H versus K is constructed. Curves of all of the titration steps will intersect in one point, which represents the true value for ∆H and K.
The data that was obtained from the isothermal titration microcalorimetry of the ADA interaction with inosine is shown in Fig. 3 . Fig. 3a shows the heat of each injection and Fig. 3b shows the heat that is related to each of the total The conformity of the dissociation binding constants (K) obtained from thermodynamic and kinetic studies is observed.
It is concluded that adenosine deaminase is inhibited by the inosine product as a competitive inhibition. Kinetic studies of ADA should be performed below the 2.5 K m concentration of the substrate. Moreover, the proposed graphical fitting method for determination of the binding constant and enthalpy of binding in the base of isothermal titration microcalorimetry data is very simple with good accuracy. It can be used in other systems.
